In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project ( www.nanotest-fp7.eu ) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed.

A numerical model for the simulation of aerosol flows via an Eulerian-Eulerian, one-way coupled, two-phase flow description is presented. An in-house computational fluid dynamics code is used to simulate the gaseous (continuous) phase, whereas a modified convective diffusion equation models particle transport. The convective diffusion equation, which includes inertial, gravitational, and diffusive particle transport, is solved by computational fluid dynamics techniques. The model is validated by comparing the calculated laminar fluid flow and particle deposition fractions to analytical and experimentally studied aerosol flows in a laminar flow 90• bend of circular cross section available in the literature. Model predictions are also compared with numerical predictions of Eulerian-Lagrangian models. Particle concentration profiles at different cross sections are calculated, and deposition sites on the wall boundary are indicated. For the range of studied particle diameters, the Eulerian-Eulerian model predicts deposition fractions satisfactorily, being in good agreement with the experimental data.

A better understanding of how properties of NPs define their interactions with cells, tissues and organs in exposed humans is a considerable scientific challenge, but one that must be addressed if there is to be safe and responsible use of biomedical NPs.

No abstract